FDA Acknowledgment Letter to Special FX Rentals

The FDA's Center for Devices and Radiological Health (CDRH) has issued an acknowledgment letter to Special FX Rentals. This notice confirms receipt of documentation and does not indicate approval or disapproval of any submissions.

FDA Variance Approval Letter

The FDA has issued a variance approval letter to Richard Lathrop, authored by CDRH. The letter, which contains restricted personally identifiable information, has been redacted and is available for download.

FDA Document - Copyrighted Content

The FDA has posted a document containing copyrighted content, identified by the docket number FDA-2026-P-2640-0004. The content itself is restricted due to copyright. This notice serves to inform the public of the document's availability and its restricted nature.

FDA Approves Labeling for RS, ANDA 202682

The U.S. Food and Drug Administration (FDA) has approved labeling for RS, as indicated by ANDA 202682. This approval was posted on March 13, 2026, and pertains to specific drug product labeling.

FDA Acknowledgment Letter to Athyna Pharma

The FDA's Center for Drug Evaluation and Research (CDER) has issued an acknowledgment letter to Athyna Pharma, LLC. This notice confirms receipt of a submission from the company.

FDA Approves Labeling for RLD, NDA N021411

The FDA has approved labeling for RLD (Reference Listed Drug) and NDA (New Drug Application) N021411. This notice indicates a regulatory action related to drug approval and labeling requirements.

FDA Complaint Document Details

The US Food and Drug Administration (FDA) has posted details regarding a complaint document. The document is available for review, though no specific details about its content or the nature of the complaint are provided in the notice.

EEOC Meeting Notice - Agency Adjudication and Determination

The Equal Employment Opportunity Commission (EEOC) has issued a notice for a virtual meeting to be held on February 26, 2026. The meeting will be closed to the public and will consider agency adjudication and determination on federal agency discrimination complaint appeals.

USOPC Athlete Ombuds Confidentiality and Privacy Policy

The US Olympic and Paralympic Committee (USOPC) Office of the Athlete Ombuds has published its confidentiality and privacy policy, as mandated by the Empowering Olympic, Paralympic, and Amateur Athletes Act of 2020. This policy outlines the conditions under which information communicated to the Ombuds office will be kept confidential and details exceptions to these rules.

DISA Senior Executive Service Performance Review Board Membership

The Defense Information Systems Agency (DISA) has published a notice regarding the membership of its Senior Executive Service Performance Review Board. This notice outlines the composition and function of the board responsible for reviewing executive performance.